Serum Ferritin as a Component of the Insulin Resistance Syndrome

作者: José-Manuel Fernández-Real , Wifredo Ricart-Engel , Enric Arroyo , Rafael Balançá , Roser Casamitjana-Abella

DOI: 10.2337/DIACARE.21.1.62

关键词:

摘要: OBJECTIVE In epidemiological studies, serum ferritin was the second-strongest determinant of blood glucose (after BMI) in regression models and third-strongest insulin BMI age). Its concentration also correlated positively with plasma triglycerides apolipoprotein B concentrations, negatively HDL 2 cholesterol. We hypothesized that could be a marker resistance. RESEARCH DESIGN AND METHODS Oral tolerance sensitivity (S I , minimal model method) were prospectively evaluated 36 healthy subjects. The relationship between metabolic control (as measured by HbA 1c levels) studied 76 consecutive NIDDM patients. RESULTS subjects, log-transformed (LOGFER) basal ( r = 0.44, P 0.007), but not BMI, age, systolic or diastolic pressure, total cholesterol, VLDL triglycerides, insulin, (all NS). Identical results obtained when two lowest quartiles separately. However, highest quartiles, LOGFER (0.50, 0.02), pressure 0.8, 0.57, 0.01), cholesterol 0.48, 0.03), 3 subtractions −0.68, −0.76, −0.55, 0.001. 0.60, 0.006), /HDL quotient −0.71, 0.001), 0.65, 0.004), uric acid 0.51, 0.38, 0.15). After adjusting for only correlations 0.7, 0.002) −0.63, 0.01) remained significant. Strong area under curve during oral test (Pearson9s 0.73, 0.001) S 1 which significant after controlling observed. (β −0.44, −0.52, 0.004) constituted independent predictors multivariate analysis (R 0.68). outpatients, 0.03) independently predicted value 0.40) multiple linear analysis. CONCLUSIONS among quotient, curve, suggest resistance syndrome. Serum may an poor diabetic patient.

参考文章(36)
Barenbrock M, Zidek W, Rahn Kh, Spieker C, Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis. Clinical Nephrology. ,vol. 40, pp. 241- 243 ,(1993)
A Dávalos, J M Fernandez-Real, W Ricart, S Soler, A Molins, E Planas, D Genís, Iron-related damage in acute ischemic stroke. Stroke. ,vol. 25, pp. 1543- 1546 ,(1994) , 10.1161/01.STR.25.8.1543
G Gallou, I Guilhem, J Y Poirier, A Ruelland, B Legras, L Cloarec, Increased serum ferritin in insulin-dependent diabetes mellitus: relation to glycemic control. Clinical Chemistry. ,vol. 40, pp. 947- 948 ,(1994) , 10.1093/CLINCHEM/40.6.947
PETER W. WILSON, DANIEL L. McGEE, WILLIAM B. KANNEL, OBESITY, VERY LOW DENSITY LIPOPROTEINS, AND GLUCOSE INTOLERANCE OVER FOURTEEN YEARS THE FRAMINGHAM STUDY American Journal of Epidemiology. ,vol. 114, pp. 697- 704 ,(1981) , 10.1093/OXFORDJOURNALS.AJE.A113240
Markku Laakso, How Good a Marker Is Insulin Level for Insulin Resistance American Journal of Epidemiology. ,vol. 137, pp. 959- 965 ,(1993) , 10.1093/OXFORDJOURNALS.AJE.A116768
David W. Reif, Ferritin as a source of iron for oxidative damage. Free Radical Biology and Medicine. ,vol. 12, pp. 417- 427 ,(1992) , 10.1016/0891-5849(92)90091-T
J.-P. Felber, E. Ferrannini, A. Golay, H. U. Meyer, D. Theibaud, B. Curchod, E. Maeder, E. Jequier, R. A. DeFronzo, Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes Diabetes. ,vol. 36, pp. 1341- 1350 ,(1987) , 10.2337/DIAB.36.11.1341